GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 306 filers reported holding GLOBUS MED INC in Q4 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,289 | +6.1% | 72 | 0.0% | 0.00% | – |
| Q2 2022 | $4,042 | -43.5% | 72 | -25.8% | 0.00% | – |
| Q1 2022 | $7,157 | +2.2% | 97 | 0.0% | 0.00% | – |
| Q4 2021 | $7,003 | -69.2% | 97 | -67.3% | 0.00% | -100.0% |
| Q3 2021 | $22,756 | -1.2% | 297 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $23,026 | +25.7% | 297 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $18,316 | +40.4% | 297 | +48.5% | 0.00% | 0.0% |
| Q4 2020 | $13,044 | -3.5% | 200 | -26.7% | 0.00% | 0.0% |
| Q3 2020 | $13,519 | +6.9% | 273 | +3.0% | 0.00% | 0.0% |
| Q2 2020 | $12,643 | +460.9% | 265 | +400.0% | 0.00% | – |
| Q1 2020 | $2,254 | -95.5% | 53 | -94.6% | 0.00% | -100.0% |
| Q3 2019 | $49,995 | +1081.9% | 978 | +878.0% | 0.00% | – |
| Q2 2019 | $4,230 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |